 NEW YORK--BUSINESS WIRE--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Misonix, Inc. NASDAQ: MSON to Bioventus Inc. is fair to Misonix shareholders. Under the terms of the agreement, Misonix stockholders may elect to receive either i 1.6839 shares of Bioventus class A common stock or ii 28.00 in cash, without interest, for each share of Misonix common stock they hold, subject to proration. Halper Sadeh encourages Misonix shareholders to click 